Center-Authored Papers

Filters: Author is Choueiri, Toni K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
V
Venook AP, Arcila ME, Benson AB, Berry DA, Camidge DR, Carlson RW, Choueiri TK, Guild V, Kalemkerian GP, Kurzrock R et al..  2014.  NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(11):1629-49. Abstract
S
Scelo G, Purdue MP, Brown KM, Johansson M, Wang Z, Eckel-Passow JE, Ye Y, Hofmann JN, Choi J, Foll M et al..  2017.  Genome-wide association study identifies multiple risk loci for renal cell carcinoma.. Nature communications. 8:15724. Abstract
M
Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Costello BA, Derweesh IH et al..  2015.  Kidney cancer, version 3.2015.. Journal of the National Comprehensive Cancer Network : JNCCN. 13(2):151-9. Abstract
Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL et al..  2009.  NCCN clinical practice guidelines in oncology: kidney cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(6):618-30.
Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M et al..  2017.  Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.. Journal of the National Comprehensive Cancer Network : JNCCN. 15(6):804-834. Abstract
Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S, Tykodi SS, Sosman JA, Procopio G, Plimack ER et al..  2015.  Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.. The New England journal of medicine. 373(19):1803-1813. Abstract
Motzer RJ, Jonasch E, Agarwal N, Beard C, Bhayani S, Bolger GB, Chang SS, Choueiri TK, Derweesh IH, Gupta S et al..  2014.  Kidney cancer, version 2.2014.. Journal of the National Comprehensive Cancer Network : JNCCN. 12(2):175-82. Abstract
Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Carducci MA, Chang SS, Choueiri TK, Hancock SL, Hudes GR et al..  2011.  Kidney cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(9):960-77.
Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, Carducci MA, Chang SS, Choueiri TK, Gupta S et al..  2012.  Testicular cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 10(4):502-35.
Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA, Choueiri TK, Figlin RA, Fishman M, Hancock SL et al..  2009.  NCCN clinical practice guidelines in oncology: testicular cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 7(6):672-93.
Markt SC, Shui IM, Unger RH, Urun Y, Berg CD, Black A, Brennan P, Bueno-de-Mesquita BH, Gapstur SM, Giovannucci E et al..  2015.  ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3).. The Prostate. 75(15):1677-81. Abstract
Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA et al..  2017.  Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma.. European urology. Abstract
G
Garcia JA, Hudes GR, Choueiri TK, Stadler WM, Wood LS, Gurtler J, Bhatia S, Joshi A, Hozak RR, Xu Y et al..  2014.  A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy.. Cancer. 120(11):1647-55. Abstract